Background. Beta-glucans are naturally occurring polysaccharides and constituents of the cell wall of certain pathogenic bacteria and fungi. They have proven healing and immunostimulating properties, linked to enhanced macrophage and natural killer cell function which likely involves specific interaction with several cell surface receptors, such as lactosylceramide, selected scavenger receptors, and dectin-1 (betaGR). In particular, glucan reduces the immunosuppressive effects of a number of agents including chemo therapy and radiation. More recent studies suggest a positive function for glucan in the immunosuppression caused by toxic agents in the environment.
INTRODUCTION
Environmental toxins have significant adverse effects on the health of both animals and man. Such toxins increase host susceptibility to infections, compromise the immune system and increase the risk of autoimmune disease. These issues have led to large epidemiological studies that attempt to establish sets of immunologically relevant end points 1 . Glucans are a major constituent of the cell wall of certain saprophytic and pathogenic fungi. For many years, they have been shown to reduce the immunosuppressive effects of a number of factors, including chemo and radiation treatment [2] [3] [4] [5] . Following discovery of the effects of glucan on bone marrow protection and activation of bone marrow progenitor cells, studies have suggested new functions for glucan. These are based on the well-known fact that glucan strongly stimulates all facets of the immune system, from nonspecific response to both branches of the specific immune system 6 . From this, emerged the hypothesis that glucan might offset or at least reduce immunosuppression caused by toxic agents.
GLUCAN AND MYCOTOXINS
Contamination of the environment from the air to the soil, represents a serious danger not only to commercially farmed animals but also to humans. Some of the most deadly and persistent contaminants of animal feed are aflatoxins. These are naturally occurring mycotoxins that are produced by many species of Aspergillus, predominantly Aspergillus flavus and Aspergillus parasiticus.
High-level aflatoxin exposure causes acute hepatic necrosis that may later result in cirrhosis or carcinoma of the liver. Acute hepatic failure manifests as hemorrhage, edema, alteration in digestion and changes to the absorption and metabolism of nutrients 7, 8 . No animal species is immune to the acute toxic effects of aflatoxins and although humans are more resistant, the current data support the danger of hepatocellular cancer in man 9 . The levels of aflatoxins in agriculture are controlled by a variety of strategies including use of fungicides and pesticides but these treatments have a significant negative impact on the environment and often incur similar health problems to aflatoxins themselves.
The first studies showed that (1-3)-β-D-glucan, particularly with the (1-6)-β-D-glucan side chains, can regulate the presence of aflatoxins. Subsequent research revealed that under physiological conditions, mostly temperature, glucan can absorb up to 50% of zearalenone molecules 10 , most probably via hydrogen bonding between the hydroxyl, lactone, and ketone groups of the zearalenone molecule with the glucan single helix and van der Waals interactions between the phenyl and the β-Dglucopyranose moieties.
Further studies focused on interactions between glucan and aflatoxin B1. These showed that glucan was involved in binding to aflotoxin B1. Using molecular methods, it was revealed that hydroxyl, lactone and ketone groups participated in formation of hydrogen bonds and van der Walls interactions between glucan and aflatoxin B1 (ref. 11 ). The first investigations of glucan as a decontaminant used insoluble glucans isolated from Saccharomyces cerevisiae 12 . A later publication showed that glucan was chemically modified to form crosslinked carboxymethyl glucan. The resulting glucan had greatly improved adsorption of the mycotoxin T-2 and zearalenome 13 . However, to further establish the exact mechanisms of the adsorption of these mycotoxins on glucans, more research will be needed, in particular using a large number of glucan derivates. The exact molecular structure of tetraalkylammonium-modified carboxymethylglucan remains to be determined too.
Another interesting study used the known fact that manno-oligosaccharides can attenuate aflatoxicosis 14 and that glucans protects DNA against oxidative stress-related damage 15 . In testing the mechanisms involved in the aflatoxin-inhibiting effects of Lentinula edodes cultures, the authors demonstrated that these cultures act as an external stimulus affecting the anti-oxidant status in the fungal cells, which subsequently inhibits aflatoxin. Glucan present in cultures activates the transcription factors related to the anti-oxidant response 16 . Based on this study, glucan acts not "only" by absorption of mycotoxins but directly reduces aflatoxin production.
When we understand that mushrooms such as L. edodes can grow directly on waste materials such as olive mill wastewaters 17 , it is clear how significant this finding might be. After all, Lentinan isolated from this mushroom has been used for treating gastric cancer for more than 30 years 18 . In addition, L. edodes-based glucans have extremely low cellular toxicity. For this reason they can be used directly in animal feed, simultaneously strengthening the immune system of animals and detoxificating their feed 19 .
GLUCAN AND OTHER TOXINS-MERCURY, PERLUOROCTANIC ACID, DEPLETED URANIUM
Glucan has been found to protect bone marrow against the toxic effects of both chemotherapy and irradiation 20, 21 , most probably via direct stimulation of bone marrow progenitor cells. It is not surprising that glucan is attracting interest as a supplement for reducing the sideeffects of cancer treatments. Additional effects of glucan were found using a model of 2.45 Ghz electromagnetic radiation and oxidative injury of the skin. This experiment showed that the prophylactic use of glucan reversed the radiation-caused changes in MDA levels and SOD activities. The authors hypothesized that glucan can offer protection against oxidative injury induced by electromagnetic radiation, most likely through its known anti-oxidant abilities 22, 23 . Our laboratory focused on the ability of yeast-derived insoluble glucan #300 to decrease the immunosuppressive actions of various immunotoxins including mercury and perluorooctanic acid. The presence of mercury salts in the environment represents a serious problem, resulting in accumulation of mercury in fish 24 and despite the fact that organic ethylmercury present in limited amounts in vaccines was apparently officially cleared from causing autism 25 , it can still have strong immunosuppressive properties 26 including lowering of cellular and humoral reactions such as phagocytosis, IL-6 and IL-12 secretion and NK cell activity. Similarly, perfluorooctanesulfonates were found to decrease humoral immunity 27 , IL-6 and IL-10 secretion 28 and natural killer cell activity 29 . Our studies showed that two-week oral administration of glucan greatly ameliorated the immunosuppressive action of mercury, including IL-6 and IL-12 production, Glucan was also tested in the case of depleted uranium toxicity. The toxic effects of this compound manifests mostly via mitochondrial dysfunction, with the most relevant toxic mechanisms believed to be oxidative stress and reactive oxygen species 34 . A detailed study showed that glucan attenuated the formation of depleted uraniuminduced mitochondrial reactive oxygen species, lipid peroxidation and glutathione oxidation. In addition, further mitochondrial dysfunction including outer membrane damage and release of cytochrome c was prevented 35 . The mechanisms by which glucan supplementation blocks or at least lowers immunosuppression are currently unclear. One option is simple stimulation of immune reactions which supplements the lowering of immunity caused by exposure to toxins. A second option might be upregulation 36 or down-regulation 37 of some important genes, such as ERCC5, CASP9, CYPIAI, CDC42, OKC, BCl-2 or NF-κB. Clearly, more research is needed before glucan can be fully established in the treatment immunotoxic disorders. The relevant activity of glucan in vitro and in vivo is summarized in Table 1 .
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antibody secretion, NK cell activity and phagocytosis of peripheral blood cells 30 . Subsequent evaluations revealed that 7 day exposure to mercury caused a significant drop in cellularity in spleen, which was fully restored by glucan supplementation (Fig. 1) . Similarly, the suppressed proliferation of T lymphocytes was returned to normal by feeding with glucan (Fig. 2) . The older data on phagocytosis were confirmed using peritoneal macrophages. The stimulation of phagocytic activity caused by glucan was strong enough not only to return the inhibited activity to normal values but to a level that was significantly higher than the phagocytosis found in PBS-treated animals (Fig. 3) .
The situation in perfluorooctanesulfonate-induced immunotoxicity closely resembled the toxicity of mercury. In all three tested immune reaction (proliferation of lymphocytes, phagocytic activity, and spleen cellularity), short-term exposure to perfluorooctanesulfonate caused significant reduction, whereas 2 weeks of food supplementation with glucan either returned the reaction to normal values or elevated it to near the level of glucan alone ( Fig.  1-3) . Previously, we showed that some of the suppression caused by perfluorooctanesulfonates can be decreased or even reversed by a glucan-resveratrol-vitamin C combination 31, 32 , but glucan alone clearly possesses similar effects. There are additional reports describing the protective effects of glucan against toxicity. One is a report evaluating the effect of glucan on hearing loss caused by amikacin. Amikacin treatment showed significant ototoxicity by causing serious deterioration of hearing at most tested frequencies. Oral administration of glucan together with amikacin limited the hearing loss 33 . In addition, glucan also showed some hearing improvement when used alone. The exact mechanisms are not known but the authors speculate that inhibition of free radical formation might be involved. 
